ESC 365 - Antidotes for direct oral anticoagulants (DOACs).

ESC Premium Access

Antidotes for direct oral anticoagulants (DOACs).

Session: New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients

Topic: Pharmacologic therapy

Speaker: Doctor A. Cohen (London, GB)

Organised by Medscape Education, supported with an educational grant by Portola

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Thomas Cohen

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

17 presentations

0 follower

5 more presentations in this session

Welcome and introductions - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Speaker: Doctor S. Goldhaber (Boston, US)

The critical unmet need of VTE prophylaxis in medically ill patients.

Speaker: Doctor S. Goldhaber (Boston, US)

DOACs to prevent VTE and to reduce the risk of stroke during hospitalization and during the first several months after hospital discharge.

Speaker: Mr M. Gibson

Case discussion - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Summary and concluding remarks - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Speaker: Doctor S. Goldhaber (Boston, US)

Access the full session

New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients

Speakers: Doctor A. Cohen, Doctor S. Goldhaber, Doctor S. Goldhaber, Mr M. Gibson, Doctor S. Goldhaber

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources